From stocktwits...
Pineapple1
Bullish
4m
$AVXL Dr Kaufman reviewed the RS 1, 2,3 trials. He did show new slides on Glutamate, how 2-73 had reduced (significantly) across the patent population (though one patent on placebo did also). The first info out was the 6 patient data set (last year), this information was for the remaining 25. He hinted that a reduction in Glutamate should have an affect on seizures, but didn't present information directly related.
Market Data 
Markets 
AI
